Archive for Spin-Off

Allostera, a Univalor’s Spin-off, closes a $17M financing

Repost from www.univalor.ca

Allostera Pharma inc. closed $17M (CAD) Series A financing.

Allostera Pharma Inc. announced yesterday that “it has secured a Series A financing of $17 million.
Four venture funds participated: iNovia Capital, Genesys Capital, BDC Venture Capital with GO Capital, and Fonds Bio-Innovation s.e.c. The proceeds of the financing will be used for the development of Allosteramers™, a new class of drugs developed by Allostera scientists that are both highly specific for their targets and designed to be orally bioavailable. Additionally with these proceeds, Allostera plans to complete preclinical studies and begin human clinical testing of its lead Allosteramer™, APG2305, a novel drug candidate for treating autoimmune diseases like psoriasis that has demonstrated oral activity in animals. The specific terms of the Series A preferred share financing were not disclosed.”

To read the press release, please click here.

Congrats to Anne-Marie, Hélène and Marc for this great job!

Leave a Comment

What’s New?

Hello,

A few weeks since my last post. I then have many news to share with you.

First, probably the most important one, you may know that Didier left Univalor. After 5 years at Univalor, he is joining MSBi Valorisation (equivalent of Univalor for McGill, Sherbrooke and Bishop’s Universities) as the General Manager. I had lots of fun (and learned a lot!) working with him. Just hope, we’ll be able to collaborate soon on some exciting projects! Thanks and Good Luck Didier!

Since we came back from Photonics West 09, we have been very busy working on new projects from Université de Montréal (Equipment for transporting thermolabile products), École Polytechnique (software for condition based maintenance, software for writing analysis) and Hopital Sainte-Justine (Quantitative clinical postural assessment Tool). Of course, as soon as our analysis is completed, I’ll give you more details here.

We have also been working with ScisWave to prepare Capital Innovation. ScisWave is one of the 9 selected companies and will be presenting at the 2009 edition (Montreal – March 25).
This year, Guy Kawasaky, Founder and CEO of Garage Technology Ventures, will be Keynote Speaker! If you don’t know him yet, I recomment you read “The Art of the Start“, the best book I have ever read on start-up creation (Thanks again Didier for recommending me to read it!).

I’m now preparing my next two trips:WBT late March, 3 projects selected, and, TechConnect Summit early May, 5 projects selected. If you’re going, I’d love the meet you there!

Last News? The February 09 edition of the Vector is now available! Check out the progress of Ptidej on page 3.

Cheers,

Thomas

PS: Don’t forget to stop by Univalor’s new website

Leave a Comment

Two Spin-off Companies of Univalor Honoured at ADRIQ award gala this year

Prevtech Microbia & Odotech, laureates of the Innovation Prizes 2008.

Play it again Sam…or should we say Prevtec! This young start-up of Valorisation-Recherche, L.P., and the Faculty of Veterinary Medicine of the Université de Montréal has received a nod from the ADRIQ as their jury has rewarded them with a price “Coup de cœur” in the category “Innovation–Product”. This extraordinary mention from the Jury recognized Prevtec’s accomplishment for the registration and commercialization of their first commercial product, ColiProtec, in Canada. Last April, Prevtec was awarded the GENESIS award, category Transfer-Emergence, from BioQuébec.

Odotech, spin-off of Polyvalor, L.P. and Ecole Polytechnique de Montreal, was awarded the prize “Partnering” by ADRIQ at the same gala. Odotech is specialized in the measurement and monitoring of odors. Odotech offers technology solutions such as: the latest-generation dynamic dilution olfactometer, odor dispersion modeling software and an automated odor monitoring and management network using electronic noses.

Leave a Comment